Neurofilament protein levels: Quantitative analysis in essential tremor cerebellar cortex

Neuroscience Letters

Volumn 518, Issue 1, 2012, Pages 49-54

  Louis, Elan D ^a,b   Ma, Karen ^a   Babij, Rachel ^a   Cortés, Etty ^b   Liem, Ronald K ^b,c   Vonsattel, Jean Paul G ^b,c   Faust, Phyllis L ^c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b New York Presbyterian Hospital ^*  (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Essential tremor; Neurodegenerative; Neurofilament proteins; Pathophysiology; Purkinje cell; Western blot

Indexed keywords

ALPHA INTERNEXIN; NEUROFILAMENT PROTEIN;

AGED; ARTICLE; BIOCHEMICAL COMPOSITION; BRAIN TISSUE; BRAIN WEIGHT; CEREBELLUM CORTEX; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENTATE NUCLEUS; ESSENTIAL TREMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; WHITE MATTER;

AGED; AGED, 80 AND OVER; AXONAL TRANSPORT; CEREBELLAR CORTEX; ESSENTIAL TREMOR; FEMALE; HUMANS; INTERMEDIATE FILAMENTS; MALE; NEUROFILAMENT PROTEINS; PHOSPHORYLATION; PURKINJE CELLS;

EID: 84861526694     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.04.054     Document Type: Article

References (26)

1. Beaulieu J.M., Nguyen M.D., Julien J.P. Late onset of motor neurons in mice overexpressing wild-type peripherin. Journal of Cell Biology 1999, 147:531-544.
2. Bermejo-Pareja F. Essential tremor - a neurodegenerative disorder associated with cognitive defects?. Nature Review of Neurology 2011, 7:273-282.
3. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica 2006, 112:389-404.
4. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003, 24:197-211.
5. Erickson-Davis C.R., Faust P.L., Vonsattel J.P., Gupta S., Honig L.S., Louis E.D. "Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor. Journal of Neuropathology and Experimental Neurology 2010, 69:262-271.
6. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Human Molecular Genetics 1994, 3:1757-1761.
7. Harasymiw J.W., Bean P. Identification of heavy drinkers by using the early detection of alcohol consumption score. Alcoholism, Clinical and Experimental Research 2001, 25:228-235.
8. Jaffe H., Veeranna, Shetty K.T., Pant H.C. Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. Biochemistry 1998, 37:3931-3940.
9. Kim S., Chang R., Teunissen C., Gebremichael Y., Petzold A. Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure. Journal of the Neurological Sciences 2011, 307:132-138.
10. Kushkuley J., Metkar S., Chan W.K., Lee S., Shea T.B. Aluminum induces neurofilament aggregation by stabilizing cross-bridging of phosphorylated c-terminal sidearms. Brain Research 2010, 1322:118-123.
11. Lees J.F., Shneidman P.S., Skuntz S.F., Carden M.J., Lazzarini R.A. The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO Journal 1988, 7:1947-1955.
12. Liem R.K. Molecular biology of neuronal intermediate filaments. Current Opinion in Cell Biology 1993, 5:12-16.
13. Liem R.K., Leung C.L. Neuronal intermediate filament overexpression and neurodegeneration in transgenic mice. Experimental Neurology 2003, 184:3-8.
14. Liu Q., Xie F., Alvarado-Diaz A., Smith M.A., Moreira P.I., Zhu X., Perry G. Neurofilamentopathy in neurodegenerative diseases. The Open Neurology Journal 2011, 5:58-62.
15. Louis E.D. Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry. The Lancet Neurology 2010, 9:613-622.
16. Louis E.D., Faust P.L., Vonsattel J.P., Honig L.S., Rajput A., Robinson C.A., Pahwa R., Lyons K.E., Ross G.W., Borden S., Moskowitz C.B., Lawton A., Hernandez N. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007, 130:3297-3307.
17. Louis E.D., Ferreira J.J. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Movement Disorders 2010, 25:534-541.
18. Louis E.D., Yi H., Erickson-Davis C., Vonsattel J.P., Faust P.L. Structural study of Purkinje cell axonal torpedoes in essential tremor. Neuroscience Letters 2009, 450:287-291.
19. Louis E.D., Zheng W., Applegate L., Shi L., Factor-Litvak P. Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 2005, 65:391-396.
20. Mirra S.S. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiology of Aging 1997, 18:S91-S94.
21. Munoz D.G., Greene C., Perl D.P., Selkoe D.J. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. Journal of Neuropathology and Experimental Neurology 1988, 47:9-18.
22. Omary M.B., Ku N.O., Tao G.Z., Toivola D.M., Liao J. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends in Biochemical Sciences 2006, 31:383-394.
23. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. Journal of the Neurological Sciences 2005, 233:183-198.
24. Rudrabhatla P., Grant P., Jaffe H., Strong M.J., Pant H.C. Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. FASEB Journal 2010, 24:4396-4407.
25. Tikka T.M., Vartiainen N.E., Goldsteins G., Oja S.S., Andersen P.M., Marklund S.L., Koistinaho J. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 2002, 125:722-731.
26. Yu M., Ma K., Faust P.L., Honig L.S., Cortes E., Vonsattel J.P., Louis E.D. Increased number of Purkinje cell dendritic swellings in essential tremor. European Journal of Neurology 2012, 19:625-630.